UniBio Intelligence Joins AWS Activate Program

Published on June 11, 2025 • 3 min read

We're thrilled to announce that UniBio Intelligence has been accepted into the AWS Activate program. This milestone marks an important step in our journey to build cutting-edge, truth-grounded AI solutions for the biotech industry.

What This Means for UniBio Intelligence

The AWS Activate program provides startups with credits, technical support, and training resources to help scale innovative solutions on AWS infrastructure. For UniBio Intelligence, this means:

  • Enhanced Infrastructure: Access to AWS's robust cloud services to power our MCP servers and AI platforms
  • Improved Scalability: Better ability to serve researchers and biotech companies worldwide with reliable, high-performance tools
  • Technical Expertise: Support from AWS experts to optimize our architecture and ensure best practices
  • Accelerated Development: Resources to rapidly iterate and deploy new features for our growing user base

This partnership reinforces our commitment to building reliable, scalable AI solutions that scientists and researchers can trust. By leveraging AWS's enterprise-grade infrastructure, we can focus on what we do best: creating tools that connect AI with authoritative biomedical knowledge.

From our MCP servers integrating databases like Open Targets and Antibody Registry, to our UbiChat platform, we're building the future of AI-powered drug discovery—and AWS Activate helps us get there faster.

Join Us on This Journey

Interested in learning more about how UniBio Intelligence is transforming biotech research with AI? Get in touch with our team to explore how our MCP servers and platforms can accelerate your research.

Contact us at contact@unibiointelligence.com